Orthokeratology Lens Market Size and Share
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 0.78 Billion |
| Market Size (2030) | USD 1.05 Billion |
| CAGR (2025 - 2030) | 6.09% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Orthokeratology Lens Market Analysis by Mordor Intelligence
The Orthokeratology Lens Market size is estimated at USD 0.78 billion in 2025, and is expected to reach USD 1.05 billion by 2030, at a CAGR of 6.09% during the forecast period (2025-2030).
Orthokeratology lenses, designed with a reverse geometry, reshape the cornea to address myopia. Commonly known as ortho-k, this noninvasive procedure involves fitting specialized contact lenses to the patient. Several factors, such as advancements in lens technology coupled with improving visual correction capabilities, increasing prevalence of hyperopia, myopia, astigmatism, and others, and increasing adoption among younger demographics due to the high burden of targeted conditions, are significantly contributing to the market growth over the forecast period.
The increasing incidence of hyperopia, myopia, astigmatism, and other visual impairments is one of the significant factors influencing market growth. For instance, the prevalence of refractive errors is more than 80.0% in older people, according to an article published in BMC Ophthalmology, a study released in January 2023. In addition, the increase in the aging population and the high prevalence of visual impairments increase the demand for orthokeratology lenses, thereby driving market growth.
Moreover, orthokeratology lenses, known for their non-surgical approach to vision correction are emerging as a preferred solution for addressing this condition. The increasing adoption of orthokeratology lenses among younger demographics is attributed to the high burden of myopia, which has become a growing public health concern globally. For instance, in April 2024, according to an article published in the National Center for Biotechnology Information, researchers conducted a study to compare the effectiveness of various myopia control methods. These methods included orthokeratology (ortho-k) and low-density red-light therapy, focusing on children aged 13 and younger with low to moderate myopia. The findings underscored ortho-k's ability to slow axial elongation by 30% to 56%, positioning it as a premier optical treatment. While other methods, such as myopia control soft contact lenses and spectacles, also demonstrated notable effects, the results highlighted the need for personalized approaches in managing myopia in children. As the demand for effective myopia management solutions grows, orthokeratology lenses are expected to address this global health concern.
Furthermore, the market is witnessing robust growth, driven by advancements in product innovation and strategic geographic expansions. For instance, in May 2023, Menicon Co. Ltd. introduced its "Menicon Z Night" orthokeratology lenses in China, which have already established popularity in Southeast Asia, Australia, and Europe. This strategic initiative is expected to enhance Menicon's market position and drive the global orthokeratology lens market's growth.
Therefore, owing to factors such as advancements in lens technology coupled with improving visual correction capabilities and the increasing prevalence of hyperopia, myopia, astigmatism, and others, the orthokeratology lens market is anticipated to witness significant growth over the forecast period. However, stringent regulations, high costs, and infection risks limit market growth and are expected to restrain it.
Global Orthokeratology Lens Market Trends and Insights
Myopia Segment is Expected to Witness Significant Growth Over the Forecast Period
Myopia, commonly known as nearsightedness, is a prevalent vision condition where distant objects appear blurry while close ones remain clear. This refractive error occurs when the eye's shape, or specific parts of it, improperly bends or refracts light rays. Furthermore, the increasing cases of refractive errors like myopia are projected to grow in the upcoming years, owing to the rising geriatric population, growing government initiatives, and other chronic conditions leading to visual impairments.
Moreover, the orthokeratology lens market is witnessing significant growth, driven by the increasing prevalence of myopia worldwide. Myopia, a standard refractive error, has become a paramount public health concern, particularly among children and adolescents. For instance, in September 2024, according to an article published in the British Journal of Ophthalmology, myopia prevalence increased by 36% during 2020 to 2023, equivalent to around 1 in every three children and teens. Based on the figures and trends up to 2023, overall global myopia prevalence is projected to reach around 40% by 2050, exceeding 740 million cases, up from 600 million in 2030. These trends underscore the growing demand for orthokeratology lenses as a non-invasive solution to manage myopia progression. The market is expected to expand further as awareness increases and advancements in lens technology continue to address the needs of individuals affected by myopia.
Furthermore, the development of innovative technologies within the field, such as advanced fitting software and lens designs, is further contributing to the growth of the myopia segment over the anticipated period. Thus, key market players are introducing novel products to streamline these advanced fitting processes and improve the effectiveness of orthokeratology lenses in myopia. For instance, in January 2023, at the 2023 Global Specialty Lens Symposium (GSLS), CooperVision Specialty EyeCare introduced its groundbreaking digital fitting tool, Visavy. This user-friendly, web-based software employs topography-guided algorithms, streamlining the design and selection process for Paragon CRT orthokeratology contact lenses specifically tailored for myopia management. These advancements are poised to strengthen the market's position by addressing the growing demand for effective myopia management solutions, driving the segment's growth over the forecast period.
Additionally, the rising prevalence of childhood myopia drives demand for orthokeratology lenses, contributing to market expansion. For instance, in Singapore, projections indicate that eight out of ten children may develop myopia, creating a significant need for management solutions. In response, key players focus on technological advancements to enhance product efficacy and strengthen their market position. For instance, in January 2022, Johnson & Johnson Vision launched ACUVUE Abiliti in Singapore, introducing the CE-marked Abiliti Overnight Therapeutic Lenses for myopia control. Singapore became one of the first Asian Pacific markets to introduce the CE-marked Abiliti Overnight Therapeutic Lenses, an advanced orthokeratology solution for myopia control. Increased innovation and regional launches are expected to accelerate market growth during the forecast period.
Hence, due to the above-mentioned factors, such as the rising geriatric population, increasing prevalence of myopia, and increasing development of innovative technologies within the field, the myopia segment is expected to witness significant growth in the upcoming years.
North America is Expected to Dominate the Orthokeratology Lens Market Over the Forecast period
North America is expected to dominate the market owing to increasing cases of eye disease and a rapidly aging population, developed healthcare infrastructure, new product launches, improved accessibility, growing awareness and public acceptance, and the presence of established players in the region. According to data published by the Centers for Disease Control and Prevention (CDC) in May 2024, vision disability is one of the top 10 disabilities among adults 18 years and older and one of the most prevalent disabling conditions among children.
The increasing demand for effective myopia management solutions is driving North America's growth of the orthokeratology lens market. Leading market players are leveraging strategic collaborations and partnerships to expand the adoption of these lenses. For instance, in June 2023, Euclid Vision Corporation appointed ABB Optical as its official licensed manufacturer and distributor for orthokeratology lenses. ABB, one of the largest distributors of soft lenses in the United States, serves nearly two-thirds of the country's eye care professionals with optical products, services, and business solutions. This collaboration is expected to significantly enhance the availability of Euclid's clinically proven Ortho K contact lenses to a broader network of eye care professionals. The increasing focus on partnerships and distribution networks will likely strengthen the market's growth trajectory in the forecast period.
Furthermore, the market is driven by increased government initiatives and consumer awareness of eye health. For instance, in May 2024, the Canadian Association of Optometrists (CAO) spearheaded a digital campaign to boost public awareness of eye health and vision care. The initiative encourages Canadians to prioritize regular eye check-ups. The campaign garnered support from various provincial optometrist associations and industry sponsors. Additionally, in March 2023, the Government of Canada showed leadership towards health care in the country. The national vision health stakeholders come together to address vision care in Canada. This collaborative effort will positively impact the orthokeratology lens market by increasing awareness and demand for vision correction solutions.
Additionally, there is an increasing demand for innovative solutions to address vision correction needs. Companies focus on developing products that enhance patient comfort and deliver effective treatment outcomes. For instance, in September 2023, AccuLens launched its FDA-cleared NewVision SC orthokeratology lens. Made from Contamac Infinite material, the lens features a larger diameter for enhanced comfort and extended wear. Its four-zone design optimally reduces myopia, while the customized base and alignment curves ensure effective treatment and daily comfort. This launch highlights AccuLens' commitment to personalized solutions and reflects the competitive dynamics of the orthokeratology lens market. Continued R&D investments are expected to drive market growth in the coming years.
Therefore, owing to the factors mentioned above, such as increasing demand for effective myopia management solutions, increased government initiatives and consumer awareness of eye health, and growing demand for innovative solutions to address vision correction needs, the growth of the studied market is anticipated in the North American region.
Competitive Landscape
The orthokeratology lens market is semi consolidated in nature due to the presence of several companies operating globally as well as regionally. Key participants are developing and launching novel products and technologies to compete with existing products, while others are acquiring and partnering with other companies trending in the market. Among the key companies are Bausch & Lomb Inc., Euclid Systems Corp., CooperVision, Johnson & Johnson Vision Care, Inc., and Alpha Corporation (Menicon Group), and among others.
Orthokeratology Lens Industry Leaders
-
Bausch & Lomb Inc.
-
Euclid Systems Corp.
-
CooperVision
-
Johnson & Johnson Vision Care, Inc.
-
Menicon Group (Alpha Corporation)
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- January 2025: EyePrint Prosthetics, Advanced Vision Technologies (AVT), and WAVE Contact Lens System merged to form WAVE Eye Care, a division specializing in fully customized specialty contact lenses. WAVE Eye Care offers Ortho-K, scleral, and corneal GP lenses, supported by advanced CAD/CAM software for precision lens design, EyePrint Impression Technology for managing complex corneas, and collaborative consulting for tailored lens designs.
- September 2023: ALPHA (Wuxi) Co., Ltd. initiated the production of Orthokeratology Lenses. ALPHA WUXI, a wholly owned subsidiary of Alpha Corporation under Menicon, specializes in manufacturing and distributing contact lenses.
Global Orthokeratology Lens Market Report Scope
Orthokeratology, commonly known as ortho-k, employs specially crafted contact lenses to reshape the cornea, enhancing vision temporarily. This ortho-K effect results from central corneal epithelial thinning and the redistribution of mid-peripheral stromal and epithelial layers.
The orthokeratology lens market is segmented into product, indication, and geography. By product, the market is segmented into overnight ortho-k lenses and daytime ortho-k lenses. By indication, the market is segmented into myopia, presbyopia, hyperopia, and astigmatism. By geography, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa. The report also offers the market size and forecasts for 17 countries across the region. For each segment, the market sizing and forecasts have been done based on revenue (USD).
| Overnight Ortho-K lenses |
| Day-time Ortho-K lenses |
| Myopia |
| Presbyopia |
| Hyperopia |
| Astigmatism |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Product | Overnight Ortho-K lenses | |
| Day-time Ortho-K lenses | ||
| By Indication | Myopia | |
| Presbyopia | ||
| Hyperopia | ||
| Astigmatism | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Middle East and Africa | GCC | |
| South Africa | ||
| Rest of Middle East and Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
How big is the Orthokeratology Lens Market?
The Orthokeratology Lens Market size is expected to reach USD 0.78 billion in 2025 and grow at a CAGR of 6.09% to reach USD 1.05 billion by 2030.
What is the current Orthokeratology Lens Market size?
In 2025, the Orthokeratology Lens Market size is expected to reach USD 0.78 billion.
Who are the key players in Orthokeratology Lens Market?
Bausch & Lomb Inc., Euclid Systems Corp., CooperVision, Johnson & Johnson Vision Care, Inc. and Menicon Group (Alpha Corporation) are the major companies operating in the Orthokeratology Lens Market.
Which is the fastest growing region in Orthokeratology Lens Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Orthokeratology Lens Market?
In 2025, the North America accounts for the largest market share in Orthokeratology Lens Market.
What years does this Orthokeratology Lens Market cover, and what was the market size in 2024?
In 2024, the Orthokeratology Lens Market size was estimated at USD 0.73 billion. The report covers the Orthokeratology Lens Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Orthokeratology Lens Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Orthokeratology Lens Market Report
Statistics for the 2025 Orthokeratology Lens market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Orthokeratology Lens analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
